Hydrophobically modified magnetic nanoparticles (MNPs) were encapsulated within the membrane of poly(trimethylene carbonate)-b-poly(L-glutamic acid) (PTMC-b-PGA) block copolymer vesicles using a nanoprecipitation process. This formulation method provides a high loading of MNPs (up to 70 wt %) together with a good control over the sizes of the vesicles (100 -400 nm). The deformation of the vesicle membrane under an applied magnetic field was evidenced by anisotropic SANS. These hybrid objects display contrast enhancement properties in Magnetic Resonance Imaging, a diagnostic method routinely used for three-dimensional and noninvasive scans of the human body.
1 They can also be guided in a magnetic field gradient. The feasibility of drug release triggered by magnetic induction was evidenced using the anticancer drug doxorubicin (DOX), which is co-encapsulated in the membrane. Magnetic polymersomes are thus proposed as multimodal drug nanocarriers for bioimaging and magneto-chemotherapy. In the new field of nanomedicine, a great variety of polymeric drug delivery nanocarriers have shown efficient entrapment and controlled release of drugs in vitro. However, evaluating the fate of the carrier after injection in vivo is a delicate task: as a consequence, an imaging probe is usually coencapsulated with the drugs in the polymer nanoparticles. Such multifunctional nanocarriers for cancer diagnostics and treatment open the field of "theranostics", i.e. combination of imaging and therapeutic functions in "all-in-one" nanoparticles. 2 Among the different nanoparticles used in biotechnological applications, superparamagnetic nanocrystals made of γ-Fe 2 O 3 around 10 nm in size are of particular interest since they are biocompatible and offer contrast enhancement in MRI. In addition, MNPs can also be implemented to induce cancer cells apoptosis. Local heating is obtained by exposure to radio-frequency magnetic fields in the frequency range 100 kHz -1MHz, due to thermal dissipation by the magnetic moments forced to oscillate at the frequency of the applied magnetic field. Hyperthermia therapy (i.e. treating by heat) has been recognized as a promising form of cancer therapy, particularly in synergy with chemo-or radio-therapy. 3 For a solid tumor located not too deep under the skin (such as melanoma), a conventional hyperthermia treatment is applied, the cancer cells being destroyed by the heat shock. We proposed a totally different strategy with a polymer vesicle delivering a drug through the temperature increase induced by radiofrequency magnetic fields not macroscopically but locally, at the scale of the membrane: the MNPs being confined inside the polymer block, the heat dissipates in the vicinity of the polymer membrane, which strongly impacts its permeability. Therefore we called this strategy "magneto-chemotherapy" as depicted on Fig. 1 . In this highlight paper, we describe a convenient way to prepare fully biodegradable polymersomes featuring a dual magnetic and thermo-responsive membrane. The hydrophobic core of membranes is made of the PTMC semi-crystalline blocks and the hydrophilic leaflets arise from the PGA polypeptide blocks of the copolymer. One pot nanoprecipitation (Fig. 1) leads to dual-loaded vesicles with iron oxide MNPs of appropriate size and coating (BEY) embedded within the membranes together with the antitumor drug doxorubicin. The amphiphilic diblock copolymer was synthesized by ringopening polymerization of γ-benzyl-L-glutamate Ncarboxyanhydride initiated by amino functionalized PTMC macroinitiator upon a previously published method.
5 PTMC 24 -b-PGA 19 presents a hydrophilic weight fraction of 50 wt % for an overall molar mass M n = 4900 g/mol with a dispersity index 1.15. On the other hand, magnetic iron oxides MNPs were synthesized in water by alkaline coprecipitation of ferrous and ferric salts followed by coating with a surfactant called Beycostat (bottom sketch on Fig 1) . Nanoprecipitation allowed reaching quantitative loading contents (LC) with controlled final sizes and low polydispersity indexes, as reported on this table for two durations of the buffer addition (PBS pH=7.4), with and without DOX.
The two-dimensional confinement of the MNPs inside the vesicular membranes was evidenced by small angle neutron and light scattering techniques and observed by transmission electron microscopy. The magnetic membranes exhibited a reversible deformation under a permanent magnetic field of moderate intensity (0.1 Tesla) as seen on Fig. 2 . Finally, the release of the anticancer drug was assayed under several heating conditions. A global heating at 37°C (melting temperature of PTMC 6 ) caused a significantly higher release than the one observed at 23°C, as explained by a more permeable membrane. But the application of an oscillating magnetic field at 23°C induced hyperthermia at a local (nanometric) scale only in the vicinity of the membrane that provoked an increase in DOX release (by 2 times), thereby evidencing the validity of the concept of magnetochemotherapy with those magnetic polymersomes.
Funding
Financial support was provided by the European Commission (FP7 CP-IP 213631-2 NANOTHER).
